Adlai Nortye (ANL) Stock Forecast & Price Target

$2.26

+0.02 (+0.89%)

(As of 02:09 PM ET)

Adlai Nortye - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 2 Analyst Ratings

Based on 2 Wall Street analysts who have issued ratings for Adlai Nortye in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 2 have given a buy rating for ANL.

Consensus Price Target

$19.50
762.83% Upside

High Forecast	$30.00
Average Forecast	$19.50
Low Forecast	$9.00

According to the 2 analysts' twelve-month price targets for Adlai Nortye, the average price target is $19.50. The highest price target for ANL is $30.00, while the lowest price target for ANL is $9.00. The average price target represents a forecasted upside of 762.83% from the current price of $2.26.

Type	Current Forecast 9/20/23 to 9/19/24	1 Month Ago 8/21/23 to 8/20/24	3 Months Ago 6/22/23 to 6/21/24	1 Year Ago 9/20/22 to 9/20/23
Consensus Rating	Buy	Buy	Buy	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	2 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$19.50	$30.00	$30.00	N/A
Forecasted Upside	762.83% Upside	230.40% Upside	230.40% Upside	N/A

This Crypto Is Set to Explode in September (Ad)

With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024.

Go here to get full details on this crypto now.

ANL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ANL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Adlai Nortye Stock vs. The Competition

Type	Adlai Nortye	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.77	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	770.54% Upside	1,006.91% Upside	7.94% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
9/4/2024	HC Wainwright 2 of 5 stars	J. Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$9.00	+232.10%
6/20/2024	Cantor Fitzgerald 3 of 5 stars	L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:10 PM ET.

ANL Forecast - Frequently Asked Questions

What is Adlai Nortye's forecast for 2024?: According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Adlai Nortye is $19.50, with a high forecast of $30.00 and a low forecast of $9.00.
Should I buy or sell Adlai Nortye stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Adlai Nortye in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ANL shares.
Does Adlai Nortye's stock price have much upside?: According to analysts, Adlai Nortye's stock has a predicted upside of 303.45% based on their 12-month stock forecasts.
What analysts cover Adlai Nortye?: Adlai Nortye has been rated by research analysts at HC Wainwright in the past 90 days.
Do Wall Street analysts like Adlai Nortye more than its competitors?: Analysts like Adlai Nortye more than other "medical" companies. The consensus rating for Adlai Nortye is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ANL compares to other companies.